References for 2023 kumamoto university research plan, KI-SEOK LEE

[1] Johannes M. Aerts et al. PNAS 105 (8) 2812-2817 (2008) doi.org/10.1073/pnas.0712309105

[2] Atul Mehta et al. Oxford PharmaGenesis; (2006) https://www.ncbi.nlm.nih.gov/books/NBK11586/

[3] Germain DP, et al. J Med Genet (2015) 5 2:353–358 http://dx.doi.org/10.1136/jmedgenet-2014-102797 

[4] RxList “ Fabrazyme “ https://www.rxlist.com/fabrazyme-drug.htm#clinpharm

[5] Shin Yoshimoto, et al. Nature 499, pages 97–101 (2013) https://doi.org/10.1038/nature12347

[6] Rui-Ming Liu Int. J. Mol. Sci. 23(4), 1989 (2022) https://doi.org/10.3390/ijms23041989

[7] Han, Y et al. Exp Mol Med 55, 1–12 (2023). https://doi.org/10.1038/s12276-022-00906-w

[8] Alessia Lo Curto et al. Cells (2021), 10(2), 356; https://doi.org/10.3390/cells10020356

[9] Hyo-Sang Do et al. eBioMedicine  VOLUME 52, 102633 (2020) doi.org/10.1016/j.ebiom.2020.102633

[10] Paula Rozenfeld et al. Mol. Genet. Metab. Volume 122, Issue 3 2017 doi.org/10.1016/j.ymgme.2017.09.004

[11] Marc Chévrier et al. Autophagy 6(5):589-99. (2010) https://doi.org/10.4161/auto.6.5.11943

